Author(s): Gopinathan Sivasankaran1, Randeep2, Gautam3, Raghuram4
Incidence of breast cancer in urban India is about 34% of all women cancer. BCT (BCS + Whole Breast Radiotherapy) is the standard of care based on various randomised trials conducted in various part of the world for early breast cancer. Overall, survival and local regional recurrence rates of BCT is comparable to that of MRM. The BCS rates are higher (60% - 70%) in west compared to India (11% - 23%).
The present study was conducted to analyse the results of breast conservation surgery.
MATERIALS AND METHODS
This study was conducted at tertiary cancer hospital and comprised of retrospective collection of prospective data of patients, who underwent BCS from August 2014 - September 2017. Patients were diagnosed with breast cancer who underwent metastatic workup and discussed in the tumour board and offered the option of BCT.
Age range was 24 - 78 years and majority was premenopausal group. Most common tumour location was in the upper outer quadrant and most common histology was infiltrating ductal carcinoma, NOS type (88 out of 100). Majority of the tumours were cT1/T2 category. Local recurrence only developed in two patients (2%) and systemic recurrence only developed in 2% of patients. Five patients (5%) developed both local and systemic recurrence.
Breast conservation therapy should be offered for all early breast cancer provided no contraindications. BCS can be done safely at all tertiary centres and results are comparable with that of western standards.